ULTRATINE FOREHEAD BIOSORBABLE IMPLANT 23200

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2009-08-20 for ULTRATINE FOREHEAD BIOSORBABLE IMPLANT 23200 manufactured by Coapt Systems.

Event Text Entries

[1190763] Nine months ago, the pt had endoscopic forehead lift with implantation of bilateral ultratines to secure the lifted forehead position. In the months following surgery, the pt developed an inflamed, cystic mass over the ultratines, which slowly enlarged, finally requiring additional surgery to remove. At surgery, an inflamed cystic cavity filled with remnants of the ultratine and what appeared to be granulomatous inflammation was observed. All material was removed. There was thinning of the cortical bone underlying the implant, and the anchor hole for the ultratine was enlarged. There was no penetration through the posterior cortical bone.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report NumberMW5012490
MDR Report Key1445403
Date Received2009-08-20
Date of Report2009-08-13
Date of Event2009-08-03
Date Added to Maude2009-08-27
Event Key0
Report Source CodeVoluntary report
Manufacturer LinkN
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Single Use0
Previous Use Code0
Event Type3
Type of Report3

Device Details

Brand NameULTRATINE FOREHEAD BIOSORBABLE IMPLANT
Generic NameULTRATINE 3.0
Product CodeNDL
Date Received2009-08-20
Catalog Number23200
Lot Number02092
Device Expiration Date2010-02-01
OperatorHEALTH PROFESSIONAL
Device Sequence No1
Device Event Key0
ManufacturerCOAPT SYSTEMS
Manufacturer Address1820 EMBARCADERO ROAD PALO ALTO CA 94303 US 94303


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2009-08-20

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.